Susquehanna International Group’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-52,700
Closed -$150K 12477
2025
Q3
$150K Buy
+52,700
New +$137K ﹤0.01% 11282
2022
Q1
Sell
-16,100
Closed -$131K 13064
2021
Q4
$131K Sell
16,100
-5,200
-24% -$51.1K ﹤0.01% 11942
2021
Q3
$269K Buy
21,300
+6,800
+47% +$94.2K ﹤0.01% 10830
2021
Q2
$224K Sell
14,500
-33,000
-69% -$555K ﹤0.01% 11346
2021
Q1
$960K Sell
47,500
-12,800
-21% -$317K ﹤0.01% 7849
2020
Q4
$1.63M Buy
60,300
+40,100
+199% +$900K ﹤0.01% 5543
2020
Q3
$374K Buy
+20,200
New +$358K ﹤0.01% 8273
2020
Q2
Sell
-25,800
Closed -$237K 10192
2020
Q1
$237K Buy
25,800
+6,400
+33% +$95.5K ﹤0.01% 8395
2019
Q4
$332K Buy
+19,400
New +$259K ﹤0.01% 7830
2019
Q3
Sell
-39,300
Closed -$613K 10207
2019
Q2
$613K Sell
39,300
-13,000
-25% -$232K ﹤0.01% 6839
2019
Q1
$959K Buy
52,300
+11,400
+28% +$202K ﹤0.01% 5116
2018
Q4
$681K Sell
40,900
-29,700
-42% -$689K ﹤0.01% 5423
2018
Q3
$1.99M Buy
70,600
+52,900
+299% +$1.52M ﹤0.01% 4004
2018
Q2
$501K Buy
17,700
+200
+1% +$5.96K ﹤0.01% 6780
2018
Q1
$551K Sell
17,500
-15,600
-47% -$493K ﹤0.01% 6427
2017
Q4
$965K Sell
33,100
-20,500
-38% -$558K ﹤0.01% 5310
2017
Q3
$1.52M Buy
+53,600
New +$1.39M ﹤0.01% 4427

Other funds holding CLLS

Susquehanna International Group's CLLS Position: Q1 2026 in Review

Susquehanna International Group increased its Cellectis (CLLS) stake by 26% in Q1 2026, buying an estimated $51.8K and bringing the position to 65,942 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #11615.

Susquehanna International Group first reported a position in CLLS in Q3 2016 and has held it in 25 quarters since. The position peaked at $1.23M in Q4 2020. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Susquehanna International Group held 65,942 shares of Cellectis worth $209K as of Q1 2026.
  • Susquehanna International Group bought 13,519 Cellectis shares in Q1 2026, an estimated $51.8K.
  • Cellectis made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11615 holding.
  • Susquehanna International Group first reported a position in Cellectis in Q3 2016 and has held it in 25 quarters since.
  • Susquehanna International Group's Cellectis position peaked at $1.23M in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.